KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Long-Term Investments (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Long-Term Investments for 14 consecutive years, with $6.1 billion as the latest value for Q4 2025.

  • Quarterly Long-Term Investments rose 26.13% to $6.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.1 billion through Dec 2025, up 26.13% year-over-year, with the annual reading at $6.1 billion for FY2025, 26.13% up from the prior year.
  • Long-Term Investments for Q4 2025 was $6.1 billion at Bio-Rad Laboratories, up from $5.1 billion in the prior quarter.
  • The five-year high for Long-Term Investments was $16.2 billion in Q3 2021, with the low at $4.8 billion in Q4 2024.
  • Average Long-Term Investments over 5 years is $8.2 billion, with a median of $7.6 billion recorded in 2022.
  • The sharpest move saw Long-Term Investments surged 93.26% in 2021, then tumbled 54.04% in 2022.
  • Over 5 years, Long-Term Investments stood at $14.4 billion in 2021, then crashed by 38.62% to $8.8 billion in 2022, then dropped by 12.83% to $7.7 billion in 2023, then plummeted by 37.14% to $4.8 billion in 2024, then grew by 26.13% to $6.1 billion in 2025.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $6.1 billion, $5.1 billion, and $5.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.